Assessment of organ dose reduction and secondary cancer risk associated with the use of proton beam therapy and intensity modulated radiation therapy in treatment of neuroblastomasHiroshi Fuji, Tetsuo Nishimura, Yuji Ishida et al.|Radiation Oncology|2013Cited by 28